IP Library › Assignment 040174/0564
Patent Assignment
Reel/Frame 040174/0564

Assignment of Assignor's Interest

Recorded: 2016-10-31 Pages: 8
Assignor
Assignee
RELIABLE BIOPHARMACEUTICAL, LLC
1945 WALTON RD., SAINT LOUIS, MISSOURI, 63114
Covered Properties (13)
Process for Preparing Fondaparinux Sodium and Intermediates Useful in the Synthesis Thereof
An Efficient and Scalable Process for the Maufacture of Fondaparinux Sodium
Sulfated Acid Amides Having Anticoagulant Properties
Patent: 5,589,588 →
Application: 08/040,112 →
Sulfated Acid Amides Having Anticoagulant Properties
Patent: 5,714,598 →
Application: 08/538,628 →
Process for the Production of 2-Halo-6-Aminopurine Derivatives
Patent: 6,252,061 →
Application: 09/274,518 →
Process for the Production of 2-Halo-6-Aminopurine Derivatives
Patent: 6,596,858 →
Application: 09/803,765 →
Publication: US 2002/0052492
Process for the Production of Pentostatin Aglycone and Pentostatin
Patent: 7,393,954 →
Application: 10/734,545 →
Publication: US 2004/0181052
Process for Preparing Fondaparinux Sodium and Intermediates Useful in the Synthesis Thereof
Patent: 8,288,515 →
Application: 12/847,719 →
Publication: US 2011/0105418
Efficient and Scalable Process for the Manufacture of Fondaparinux Sodium
Patent: 8,420,790 →
Application: 12/915,864 →
Publication: US 2012/0116066
Process for Perparing Fondaparinux Sodium and Intermediates Useful in the Synthesis Thereof
Patent: 8,703,923 →
Application: 13/618,786 →
Publication: US 2013/0102764
Efficient and Scalable Process for the Manufacture of Fondaparinux Sodium
Patent: 8,987,430 →
Application: 13/791,178 →
Publication: US 2013/0261291
Processes for the Preparation of Regadenoson and a New Crystalline Form Thereof
Patent: 8,859,522 →
Application: 14/112,173 →
Publication: US 2014/0045781
Process for Perparing Fondaparinux Sodium and Intermediates Useful in the Synthesis Thereof
Patent: 9,255,119 →
Application: 14/256,235 →
Publication: US 2015/0018537
Related Assignments (8)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Nov 1, 2013
From: WOOLDRIDGE, LUZVIMINDA T; MA, CHUN; NADJI, SOURENA
To: RELIABLE BIOPHARMACEUTICAL CORPORATION
Reel/Frame 031530/0463 →
Assignment of Assignor's Interest Nov 10, 2016
From: RELIABLE BIOPHARMACEUTICAL CORPORATION
To: RELIABLE BIOPHARMACEUTICAL, LLC
Reel/Frame 040277/0548 →
Security Agreement Dec 14, 2016
From: RELIABLE BIOPHARMACEUTICAL, LLC
To: CITIBANK, N.A., AS COLLATERAL AGENT
Reel/Frame 040913/0118 →
Release (Reel 040913 / Frame 0118) Nov 27, 2017
From: CITIBANK, N.A.
To: RELIABLE BIOPHARMACEUTICAL, LLC
Reel/Frame 044511/0265 →
Security Agreement Nov 28, 2017
From: AVANTOR PERFORMANCE MATERIALS, LLC; NUSIL TECHNOLOGY LLC; APPLIED SILICONE COMPANY LLC; RELIABLE BIOPHARMACEUTICAL, LLC
To: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
Reel/Frame 044811/0400 →
Security Agreement Nov 29, 2017
From: AVANTOR PERFORMANCE MATERIALS, LLC; NUSIL TECHNOLOGY LLC; APPLIED SILICONE COMPANY LLC; RELIABLE BIOPHARMACEUTICAL, LLC
To: THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., AS NOTES COLLATERAL AGENT
Reel/Frame 044528/0960 →
Security Agreement (Notes) Nov 6, 2020
From: AVANTOR FLUID HANDLING, LLC; AVANTOR PERFORMANCE MATERIALS, LLC; NUSIL TECHNOLOGY LLC; RELIABLE BIOPHARMACEUTICAL, LLC
To: THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., AS NOTES COLLATERAL AGENT
Reel/Frame 054343/0414 →
Termination and Release of Security Interest in Patents Nov 16, 2020
From: THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A.
To: AVANTOR PERFORMANCE MATERIALS, LLC; NUSIL TECHNOLOGY LLC; APPLIED SILICONE COMPANY LLC; RELIABLE BIOPHARMACEUTICAL, LLC
Reel/Frame 054440/0877 →